- Previous close
0.0080 - Open
0.0090 - Bid 0.0090 x --
- Ask 0.0100 x --
- Day's range
0.0090 - 0.0090 - 52-week range
0.0050 - 0.0120 - Volume
893,200 - Avg. Volume
1,500,679 - Market cap (intra-day)
9.278M - Beta (5Y monthly) 0.89
- PE ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings date --
- Forward dividend & yield --
- Ex-dividend date 5 May 2014
- 1y target est
--
Meta Health Limited, an investment holding company, engages in metal stamping and manufacturing of tools and fixtures in Singapore, Thailand, Malaysia, and China. The company operates through two segments, Metal and Healthcare. It also operates IoT platform needed for chronic disease management; smart hospital platform for secondary to tertiary hospital sector; and social e-commerce platform for community group buying, as well as offers clinic based and home care services. In addition, the company trades in tools, components, product assemblies, and related products; retails health supplements, health gain products, and food products through e-commerce sales channels; and offers clinics, medication delivery, and other general medical services. It serves multi-national corporations, electronic manufacturing services, and small-medium enterprises. The company was formerly known as Metal Component Engineering Limited and changed its name to Meta Health Limited in January 2022. Meta Health Limited was founded in 1987 and is headquartered in Singapore.
www.metahealth.sg--
Full-time employees
31 December
Fiscal year ends
Industrials
Sector
Metal Fabrication
Industry
Related news
View more
Performance overview: 5DX.SI
Trailing total returns as of 11/09/2024, which may include dividends or other distributions. Benchmark is
.YTD return
1-year return
3-year return
5-year return
Compare to: 5DX.SI
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: 5DX.SI
View moreValuation measures
Market cap
8.25M
Enterprise value
9.43M
Trailing P/E
--
Forward P/E
--
PEG ratio (5-yr expected)
--
Price/sales (ttm)
3.69
Price/book (mrq)
4.26
Enterprise value/revenue
6.36
Enterprise value/EBITDA
-3.01
Financial highlights
Profitability and income statement
Profit margin
0.00%
Return on assets (ttm)
-6.52%
Return on equity (ttm)
-216.11%
Revenue (ttm)
1.48M
Net income avi to common (ttm)
-1.96M
Diluted EPS (ttm)
-0.0100
Balance sheet and cash flow
Total cash (mrq)
1.93M
Total debt/equity (mrq)
--
Levered free cash flow (ttm)
1.76M